GMP Cell Therapy Consumables Global Market Report 2024

The GMP Cell Therapy Consumables Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The GMP Cell Therapy Consumables Market:
https://www.thebusinessresearchcompany.com/report/gmp-cell-therapy-consumables-global-market-report

According to The Business Research Company’s GMP Cell Therapy Consumables Global Market Report 2024, The gmp cell therapy consumables market size has grown exponentially in recent years. It will grow from $14.13 billion in 2023 to $18.25 billion in 2024 at a compound annual growth rate (CAGR) of 29.2%. The growth in the historic period can be attributed to growing investments in regenerative medicine, advancements in cell therapy research, clinical trials and approvals, increasing prevalence of chronic diseases, rising awareness of personalized medicine.

The gmp cell therapy consumables market size is expected to see exponential growth in the next few years. It will grow to $46.86 billion in 2028 at a compound annual growth rate (CAGR) of 26.6%. The growth in the forecast period can be attributed to expansion of cell therapy applications, global increase in cell therapy trials, regulatory support for cell therapies, emergence of advanced cell therapy platforms, globalization of cell therapy manufacturing. Major trends in the forecast period include investments in manufacturing infrastructure, technological innovations in cell processing, collaborations and partnerships, digitalization and data integration, strategic alliances and mergers.

The surge in drug discovery is expected to propel the growth of the GMP cell therapy consumables market going forward. Drug discovery refers to discovering potential new medicinal entities by combining computational, experimental, translational, and clinical models. Advances in molecular biology, genetics, bioinformatics, and high-throughput screening techniques have revolutionized drug discovery. These technologies enable scientists to understand disease mechanisms better, identify potential drug targets, and screen large libraries of compounds for drug candidates more efficiently. This rise in drug discovery contributes to the growth of the GMP cell therapy consumables market. For Instance, in January 2023, according to Food and Drug Administration, a US-based federal agency of the Department of Health and human services, 37 new drugs and therapeutic biological products were approved by FDA’s Centre for Drug Evaluation and Research (CDER) in the US, in 2022 for various indications. Therefore, the surge in drug discovery is driving the growth of the GMP cell therapy consumables market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12014&type=smp

The gmp cell therapy consumables market covered in this report is segmented –

1) By Product: Kits, Reagents or Molecular biology reagents, Growth Factors or Cytokines and Interleukins, Other Products
2) By Cell Therapy: NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, Other cell therapies
3) By Process: Cell Collection And Characterization or Sorting and Separation, Cell Culture and Expansion or Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution or Handling, Process Monitoring and Control or Readministration or Quality Assurance, Other Processes
4) By End-Use: Clinical, Commercial, Research

Product Innovations are a key trend gaining popularity in the GMP cell therapy consumables market. Companies operating in the GMP cell therapy consumables market are adopting new technologies to sustain their position in the market. For instance, in March 2021, Thermo Fischer Scientific, a US-based supplier of scientific instrumentation, reagents and consumables, and software services, launched 3,000 and 5,000 L single-use bioreactors named HyPerforma DynaDrive single-use bioreactors. This system provides an improved turn-down ratio, enhanced mixing, and increased scalability. Additionally, the company claims that the solution results in a smaller vessel footprint and uses technology optimized for perfusion cell culture operations to help conserve manufacturing suite space.

The gmp cell therapy consumables market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Major Players: